BBBernd Bohmeier

Bernd Bohmeier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bernd Bohmeier has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Adedolapo Olorunfemi

    Center for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria

    1 shared publication
  • Adekunle Olowe

    Center for Emerging and Re-emerging Infectious Diseases, Ladoke Akintola University of Technology, Ogbomoso, Nigeria

    1 shared publication
  • Amy Gaye

    Centre International de recherche, de Formation en Genomique Appliquee et de Surveillance Sanitaire (CIGASS), Dakar, Senegal

    1 shared publication
  • Arsène Zongo

    Unit for Public Health Laboratory Support, Centre for International Health Protection (ZIG), Robert Koch Institute, Berlin, Germany

    1 shared publication
  • Awa B. Deme

    Centre International de recherche, de Formation en Genomique Appliquee et de Surveillance Sanitaire (CIGASS), Dakar, Senegal

    1 shared publication
  • Bassirou Ngom

    Centre International de recherche, de Formation en Genomique Appliquee et de Surveillance Sanitaire (CIGASS), Dakar, Senegal

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Continental-scale genomic surveillance of Plasmodium falciparum malaria across sub-Saharan Africa with rapid nanopore sequencing

    by Mulenga Mwenda, Karolina Mosler, Bernd Bohmeier, Miriam Chomba, Welmoed van Loon, Brenda Mambwe, Amy Gaye, Adedolapo Olorunfemi, Salma Suliman, Nassandba Julien Yanogo, et al.

    In sub-Saharan Africa, continental-scale genomic surveillance of Plasmodium falciparum malaria is needed to track the spread of drug and diagnostic resistance, as well as monitor parasite evolutionary responses to vaccine rollout. Yet continental-scale implementation is hindered by a lack of genomic approaches suitable for local laboratories, and the vastness of the continent. Here, we initiate a decentralised scale-up of P. falciparum genomic surveillance by locally sequencing and analysing 1065 samples across six African countries in one year. We achieve this with a novel nanopore sequencing protocol that is rapid (~5 hr) and cost-effective (<$25 USD/sample), providing surveillance of antimalarial drug resistance genes, hrp2/3 deletions, the vaccine target csp , and the polymorphic gene ama1 . We couple this to a laptop-based bioinformatics dashboard that runs offline and displays mapping and variant calling results in real-time. We demonstrate robust sequencing coverage across parasitemia levels and laboratories, accurate identification of antimalarial resistance markers and hrp2/3 deletions; and, with a novel variant caller, sensitive detection of mutations carried by minor clones. Our approach will accelerate genomic surveillance of P. falciparum malaria across sub-Saharan Africa at a time of urgent need.